Learn more about the theory and practice of benefit-cost analysis by reading the new Reference Case Guidelines for Benefit-Cost Analysis in Global Health and Development.
Following a call for concept notes last year, the VoVRN Secretariat, members of the Steering Committee, and external expert reviewers identified promising studies to recommend for funding. Learn more about these projects here
Evaluating vaccination programs according to their broad socioeconomic benefits, beyond their health benefits, will help to address the twin problems of vaccine underutilization and weak incentives for vaccine innovation. See more here
The benefit-cost analysis guidance project team is seeking case studies that examine the application of the methodological recommendations, focusing on immunization and other policies. Read more here
A two-day Methods and Case Studies workshop in Boston seek to develop reference case guidelines for benefit-cost analysis in global health and development. Discussants include Larry Summers, Sue Goldie, and Dean Jamison. Read more here
Researchers have identified vaccination benefits that should be incorporated into economic evaluations to reflect vaccination’s full value. The article discusses data sources, methods, and research questions to be explored. See more here
This is the result of a new study, published in the journal Health Affairs. Projected vaccination rates of 94 low- and middle-income countries from 2011 to 2020 were used to determine the economic benefits. See more here